SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-018147
Filing Date
2022-09-07
Accepted
2022-09-07 06:47:04
Documents
12
Period of Report
2022-09-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K beam-20220902.htm   iXBRL 8-K 54574
  Complete submission text file 0000950170-22-018147.txt   167903

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20220902.xsd EX-101.SCH 2451
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20220902_pre.xml EX-101.PRE 9441
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20220902_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT beam-20220902_htm.xml XML 4518
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 221229878
SIC: 2836 Biological Products, (No Diagnostic Substances)